Journal profile · Medicine-Pulmonary and Respiratory Medicine
Pulmonary Circulation
ISSN 2045-8932 · eISSN 2045-8940 · SAGE Publications Inc. · UNITED STATES
Pulmonary Circulation: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.36; fully open access; APC about USD 2,310; median 110 days to acceptance (103 articles, last 24 months); 208 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pulmonary Circulation is published by SAGE Publications Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors and Heart Failure Treatment and Management, together about 53.8% of its articles. Its main subfields are Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Pulmonary Circulation, the official journal of the Pulmonary Vascular Research Institute (PVRI), is a peer-reviewed medical research journal. Our focus is to publish high-quality, original research and key reviews in the fields of pulmonary circulation and pulmonary vascular disease. What We Publish We serve as a unique platform for showcasing novel findings and advanced discoveries in: Lung Vascular Biology: The fundamental science of how the lungs' blood vessels function. Pulmonary Vascular Disease: The study and treatment of conditions affecting the pulmonary arteries, veins, and capillaries. Lung Injury and Right Heart Failure: The connection between lung damage and its effects on the right side of the heart. Our goal is to advance scientific knowledge and accelerate the development of new therapeutic approaches to improve survival rates and quality of life for patients with pulmonary hypertension and other cardiopulmonary and vascular diseases worldwide.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pulmonary and Respiratory Medicine
Editor-in-chief Actions ToolsPublisher website
Editorial board by country: 4 in mainland China (about 4%); most named United States 70, United Kingdom 15, Germany 5, Mainland China 4, Canada 4 (112 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pulmonary Hypertension Research and TreatmentsMedicine39.3%
- Cardiovascular Function and Risk FactorsMedicine8.3%
- Heart Failure Treatment and ManagementMedicine6.2%
- Cardiovascular Issues in PregnancyMedicine6.1%
- Vascular Anomalies and TreatmentsMedicine5.3%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine4.2%
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine3.9%
- Congenital Heart Disease StudiesMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.36LetPub ·
- CiteScore 2026-06
- 4.2LetPub ·
- SJR 2026-06
- 0.76LetPub ·
- SNIP 2026-06
- 0.78LetPub ·
- h-index
- 32LetPub ·
- h-index
- 75OpenAlex ·
- i10-index
- 924OpenAlex ·
- 2-year mean citedness
- 1.92OpenAlex ·
- Self-citation rate
- 8.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 147LetPub ·
Articles by year OpenAlex count · 2,216 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 177 | 177 | 49 |
| 2025 | 208 | 208 | 295 |
| 2024 | 161 | 161 | 702 |
| 2023 | 140 | 140 | 1,245 |
| 2022 | 163 | 163 | 1,723 |
| 2021 | 153 | 153 | 1,991 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
110 daysMedian, submission to acceptance · P25–P75 72 days – 161 days
- Acceptance to online
- median 12 days (104 articles)
- Submission to online
- median 125 days
- Sample
- 103 articles with submission and acceptance dates (408 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 15 weeksLetPub ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,310 / EUR 1,940 / GBP 1,730 | — | — | |
| LetPub | USD 2,310 / GBP 1,730 / EUR 1,940 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Graphical abstract
- Optional
Article types accepted3, with length limits
- case reportintervention in a unique clinical case. Case reports should be no more than 1,000 words, and include no more than 1 table or figure, and no more thmain text ≤ 1,000 words
- lettersmall cohort of patients. The research letter should be no more than 1,500 words including an abstract of no more than 50 words, no more thamain text ≤ 1,500 words
- research articleResearch Article: Original research, controlled trials, case studies, feasibility and pilot studies, qualitative and quantitative studies. Abstract no more than…Length not stated
Policy excerpts from the journal's websiteOpen access
- Open access
Open access, peer-reviewed; articles published under Creative Commons license and freely available online immediately upon publication. Model summary
Pulmonary Circulation is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publications Inc.
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 2045-8932
- Electronic ISSN
- 2045-8940
- Society / sponsor
- Pulmonary Vascular Research Institute
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Pulmonary Circulation
What CAS zone is Pulmonary Circulation in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pulmonary Circulation is in Zone 4 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems / Respiratory System. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pulmonary Circulation?
The latest impact factor listed by LetPub is 2.36; CiteScore 4.2, h-index 75.
How long does peer review take at Pulmonary Circulation?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 110 days (interquartile range 72–161 days); authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Pulmonary Circulation based?
Of the 112 board members whose country the journal's board page names, 4 (about 4%) are in mainland China; the countries named most often are United States (70), United Kingdom (15) and Germany (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Pulmonary Circulation?
According to LetPub and DOAJ records, Pulmonary Circulation is indexed in SCIE, Scopus and DOAJ.
Is Pulmonary Circulation open access, and what is the APC?
Pulmonary Circulation is a fully open-access journal. APC about USD 2,310.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .